未登录.png)
分享.png)
收藏First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma
Le Tourneau, C.; Dreno, B.; Kirova, Y.; Grob, J. J.; Jouary, T.; Dutriaux, C.; Thomas, L.; Lebbe, C.; Mortier, L.; Saiag, P.; Avril, M. F.; Maubec, E.; Joly, P.; Bey, P.; Cosset, J. M.; Sun, J. S.; Asselain, B.; Devun, F.; Marty, M. E.; Dutreix, M. 分享 收藏 70 GY VERSUS 80 GY IN LOCALIZED PROSTATE CANCER: 5-YEAR RESULTS OF GETUG 06 RANDOMIZED TRIAL70 GY与80 GY治疗局限性前列腺癌: GETUG 06随机试验的5年结果Beckendorf, Veronique; Guerif, Stephane; Le Prise, Elisabeth; Cosset, Jean-Marc; Bougnoux, Agnes; Chauvet, Bruno; Salem, Naji; Chapet, Olivier; Bourdain, Sylvain; Bachaud, Jean-Marc; Maingon, Philippe; Hannoun-Levi, Jean-Michel; Malissard, Luc; Simon, Jean-Marc; Pommier, Pascal; Hay, Men; Dubray, Bernard; Lagrange, Jean-Leon; Luporsi, Elisabeth; Bey, Pierre 分享 收藏 分享 收藏 Tolerance to high dose proton therapy of normal CNS structures in childrenHabrand, J. L.; Bolle, S.; Petras, S.; Schneider, R.; Alapetite, C.; Helfre, S.; Feuvret, L.; De Marzi, L.; Beaudre, A.; Bey, P. 分享 收藏 分享 收藏 The getug 70 GY vs. 80 GY randomized trial for localized prostate cancer:: Feasibility and acute toxicitygetug 70 GY vs。80 GY局部前列腺癌的随机试验: 可行性和急性毒性Beckendorf, V; Guérif, S; Le Prisé, E; Cosset, JM; Lefloch, O; Chauvet, B; Salem, N; Chapet, O; Bourdin, S; Bachaud, JM; Maingon, P; Lagrange, JL; Malissard, L; Simon, JM; Pommier, P; Hay, MH; Dubray, B; Luporsi, E; Bey, P 分享 收藏 Efficacy and morbidity of arc-therapy radiosurgery for cerebral arteriovenous malformations: A comparison with the natural historyBollet, MA; Anxionnat, R; Buchheit, I; Bey, P; Cordebar, A; Jay, N; Desandes, E; Marchal, C; Lapeyre, M; Aletti, P; Picard, L 分享 收藏 分享 收藏 分享 收藏 SOR: project methodologyFervers, B; Hardy, J; Blanc-Vincent, MP; Theobald, S; Bataillard, A; Farsi, F; Gory, G; Debuiche, S; Guillo, S; Renaud-Salis, JL; Pinkerton, R; Bey, P; Philip, T 分享 收藏 分享 收藏 Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer - Preliminary results前列腺癌3D-CRT剂量递增: 法国前列腺癌适形3D放疗剂量递增研究-初步结果Bey, P; Carrie, C; Beckendorf, V; Ginestet, C; Aletti, P; Madelis, G; Luporsi, E; Pommier, P; Cowen, D; Gonzague-Casabianca, L; Simonian-Sauve, M; Maingon, P; Naudy, S; Lagrange, JL; Marcie, S 分享 收藏 Postoperative brachytherapy alone for T1-2 N0 squamous cell carcinomas of the oral tongue and floor of mouth with close or positive marginsLapeyre, M; Hoffstetter, S; Peiffert, D; Guérif, S; Maire, F; Dolivet, G; Toussaint, B; Mundt, A; Chassagne, JF; Simon, C; Bey, P 分享 收藏 分享 收藏 分享 收藏 分享 收藏 Breast cancer in patients treated for Hodgkin's disease: Clinical and pathological analysis of 76 cases in 63 patientsCutuli, B; Dhermain, F; Borel, C; de Larochefordiere, A; Graic, Y; de Lafontan, B; Dilhyudy, JM; Mignotte, H; Tessier, E; Tortochaux, J; N'Guyen, T; Bey, P; Le Mevel-Le Pourhiet, A; Velten, M; Arriagada, R 分享 收藏 分享 收藏 Results of a European randomized trial of Etanidazole combined with radiotherapy in head and neck carcinomasEschwege, F; SanchoGarnier, H; Chassagne, D; Brisgand, D; Guerra, M; Malaise, EP; Bey, P; Busutti, L; Cionini, L; NGuyen, T; Romanini, A; Chavaudra, J; Hill, C 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
